Skip to main content
. 2021 Nov 17;14:4809–4819. doi: 10.2147/IDR.S334046

Table 1.

Demographic Data and Clinical Characteristics of the Study Subjects at the Beginning of Antiretroviral Therapy (n=6637)

Variables Thrombocytopenia (n=176) Thrombocytosis (n=388) Normal (n=6073)
Age (years) 34(29, 46) 30(25, 38) 30(26, 37)
Sex
 Male 166 (94.3) 364(93.8) 5820(95.8)
 Female 10 (5.7) 24(6.2) 253(4.2)
Transmission route
 Homosexual 115 (65.3) 294(75.8) 4893(80.6)
 Heterosexual 38 (21.6) 58(14.9) 733(12.1)
 Other/unknown 23 (13.1) 36(9.3) 447(7.3)
WHO clinical stage
 I–II 152(86.4) 347(91.1) 5513(92.2)
 III–IV 24 (13.6) 34(8.9) 469(7.8)
BMI (kg/m2)
 18.5–24.0 88 (66.2) 186(61.4) 3136(65.6)
 < 18.5 19 (14.3) 40(13.2) 472(9.9)
 >24.0 26 (19.5) 77(25.4) 1171(24.5)
HBsAg
 Negative 148(85.5) 363(95.3) 5649(94.7)
 Positive 25(14.5) 18(4.7) 314(5.3)
Anti-HCV
 Negative 166(96.0) 378(99.5) 5833(98.0)
 Positive 7(4.0) 2(0.5) 119(2.0)
Syphilis
 Negative 105(64.4) 205(59.8) 3688(64.9)
 Positive 58(35.6) 138(40.2) 1992(35.1)
Baseline VL (copies/mL)
 <100,000 88(51.5) 237(62.7) 4143(70.4)
 ≥100,000 83(48.5) 141(37.3) 1740(29.6)
Baseline CD4 count (cells/μL)
 <350 144(82.8) 219(56.9) 3595(60.0)
 ≥350 30(17.2) 166(43.1) 2397(40.0)
Baseline CD4/CD8 ratio
 <0.4 151(87.3) 272(71.0) 4238(71.9)
 ≥0.4 22(12.7) 111(29.0) 1658(28.1)
WBC (×109 /L)
 ≥4.0 106(60.2) 353(91.0) 5288(87.1)
 <4.0 70(39.8) 35(9.0) 785(12.9)
HGB (g/L)
 ≥110(Female) or ≥120(Male) 119(67.6) 308(79.4) 5651(93.1)
 <110(Female) or >120(Male) 57(32.4) 80(20.6) 422(6.9)
NLR
 <2.0 79(46.5) 168(45.8) 3589(61.2)
 2.0–4.0 60(35.3) 130(35.4) 1791(30.5)
 >4.0 31(18.2) 69(18.8) 488(8.3)

Notes: Data are presented as n (%), or median (interquartile range). Variable had missing values: WHO clinical stage = 98; BMI = 1422; HBV = 120; HCV =132; Syphilis = 451; VL = 205; CD4 count = 86; CD4/CD8 ratio = 185; NLR = 232.

Abbreviations: WHO, world health organization; BMI, body mass index; HBsAg, hepatitis B surface antigen; Anti-HCV, antibody to hepatitis C virus; VL, viral load; WBC, white blood cell; HGB, haemoglobin; NLR, neutrophil-lymphocyte ratio.